Journal
ARTHRITIS RESEARCH & THERAPY
Volume 23, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13075-021-02427-9
Keywords
Osteoarthritis; Gut microbiota; Gut dysbiosis; Inflammation; Exercise; Fecal microbiota transplantation
Categories
Funding
- National Natural Science Foundation of China [81772440]
Ask authors/readers for more resources
Osteoarthritis (OA) is a common musculoskeletal disease characterized by degeneration of articular cartilage, with potential interaction with gut microbiota for management. Future research directions include more intervention studies on gut microbiota and gene regulation influencing the gut microbiota-OA relationship.
Osteoarthritis (OA) is one of the most frequent musculoskeletal diseases characterized by degeneration of articular cartilage, subchondral bone remodeling, and synovial membrane inflammation, which is a leading cause of global disability, morbidity, and decreased quality of life. Interpreting the potential mechanisms of OA pathogenesis is essential for developing novel prevention and disease-modifying therapeutic interventions. Gut microbiota is responsible for a series of metabolic, immunological, and structural and neurological functions, potentially elucidating the heterogeneity of OA phenotypes and individual features. In this narrative review, we summarized research evidence supporting the hypothesis of a gut-joint axis and the interaction between gut microbiota and the OA-relevant factors, including age, gender, genetics, metabolism, central nervous system, and joint injury, elucidating the underlying mechanisms of this intricate interaction. In the context, we also speculated the promising manipulation of gut microbiota in OA management, such as exercise and fecal microbiota transplantation (FMT), highlighting the clinical values of gut microbiota. Additionally, future research directions, such as more convincing studies by the interventions of gut microbiota, the gene regulation of host contributing to or attributed to the specific phenotypes of gut microbiota related to OA, and the relevance of distinct cell subgroups to gut microbiota, are expected. Moreover, gut microbiota is also the potential biomarker related to inflammation and gut dysbiosis that is able to predict OA progression and monitor the efficacy of therapeutic intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available